Core as a Novel Viral Target for Hepatitis C Drugs

Hepatitis C virus (HCV) infects over 130 million people worldwide and is a major cause of liver disease. No vaccine is available. Novel specific drugs for HCV are urgently required, since the standard-of-care treatment of pegylated interferon combined with ribavirin is poorly tolerated and cures les...

Descripción completa

Detalles Bibliográficos
Autores principales: Strosberg, Arthur Donny, Kota, Smitha, Takahashi, Virginia, Snyder, John K., Mousseau, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185734/
https://www.ncbi.nlm.nih.gov/pubmed/21994704
http://dx.doi.org/10.3390/v2081734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185734/
https://www.ncbi.nlm.nih.gov/pubmed/21994704
http://dx.doi.org/10.3390/v2081734

Ejemplares similares